Only if you also have at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or PCOS
What else you should know If you don't lose 4% of your weight after 16 weeks of taking liraglutide, your doctor may tell you to stop taking it because it's unlikely to work for you
Pelvic floor symptoms/pain : consider pelvic floor physiotherapy referral and evaluation for dermatoses
When interpreted with clinical history by a qualified provider, these insights can guide personalized dosing, formulation selection, and management planning
The clinical trial evidence indicates that tirzepatide is associated with better glycemic control and weight reduction than the conventional GLP-1 monotherapy, with the SURPASS clinical trial program being associated with HbA1c changes of up to 2.4% compared to baseline and weight reduction of more than 22% of the baseline weight at the highest dosage